National Centre for
Pharmacoeconomics
NCPE Ireland
About Us
Current Staff
News
Glossary
Contact Us
Vacancies
Home
Submission Process
HTA Guidelines
Process Flowchart
Submission Templates
Pharmacoeconomic Evaluations
Drugs
Vaccines
Diagnostics and Other Technologies
Publications
Peer Reviewed Papers
Abstracts
Reports
Research
Pharmacoeconomic Research
Education
COVID-19
For Patients
Archive
2021
IUB™ Ballerine® MIDI 15mm diameter SCU300B. HTA ID: 20062
Guselkumab (Tremfya®) for psoriatic arthritis. HTA ID 20059
Semaglutide (Rybelsus®) HTA ID: 20011
Polatuzumab vedotin (Polivy®) HTA ID: 19052
Avatrombopag (Doptelet®). HTA ID: 20058
Omeprazole (Pedippi®) 2mg/ml powder for oral suspension (HTA ID: 20049)
Liraglutide (Saxenda®) HTA ID: 19039
Atezolizumab (Tecentriq®) in combination with bevacizumab. HTA ID: 20060
Acalabrutinib (Calquence®) HTA ID: 20063
Baricitinib (Olumiant®) for moderate to severe atopic dermatitis. HTA ID: 20056
Opicapone (Ongentys®). HTA ID: 20055
Mogamulizumab (Poteligeo®). HTA ID: 20061
Carfilzomib (Kyprolis®) in combination with daratumumab and dexamethasone (CAR+DAR+DEX). HTA ID: 20054
Nivolumab (Opdivo®) as monotherapy for unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma (2L). HTA ID: 20057
Galcanezumab (Emgality®). HTA ID 20052
Pertuzumab and trastuzumab (Phesgo®). HTA ID: 20053
2020
Fluocinolone acetonide intravitreal implant (Iluvien®) for non-infectious uveitis. HTA ID: 20050
Pembrolizumab (Keytruda®) in combination with axitinib (Inlyta®) for 1L RCC. HTA ID: 19027
Amikacin Sulfate (Arikayce® liposomal nebuliser dispersion). HTA ID: 20048
Inclisiran (Leqvio®). HTA ID: 20051
Ozanimod (Zeposia®). HTA ID: 20045
Sodium hydrogen carbonate (Thamicarb®). HTA ID: 20043
Delafloxacin (Quofenix®). HTA ID: 20038
Filgotinib (Jyseleca®). HTA ID: 20047
Nusinersen (Spinraza®). HTA ID: 20044
Venetoclax (Venclyxto®) in combination with obinutuzumab (Gazyvaro®). HTA ID: 20046
Imipenem/cilastatin/relebactam (Recarbrio®). HTA ID: 20040
Infliximab (Remsima® subcutaneous). HTA ID: 20042
Glasdegib (Daurismo®) in combination with low-dose cytarabine. HTA ID: 20041
Encorafenib (Braftovi®) in combination with cetuximab. HTA ID: 20037
Tafamidis (Vyndaqel®). HTA ID: 20017
Atezolizumab (Tecentriq®) in combination with carboplatin and etoposide for 1L ES-SCLC HTA ID: 19030
Atezolizumab (Tecentriq®) HTA ID: 20039
Voretigene neparvovec (Luxturna®) HTA ID: 19041
Talazoparib (Talzenna®) HTA ID: 19032
Fremanezumab (Ajovy®)
Alpelisib (Piqray®) HTA ID: 20035
Atezolizumab (Tecentriq®) for triple-negative breast cancer.
Nintedanib (Ofev®) HTA ID: 20034
Abemaciclib (Verzenios®) HTA ID: 20033
Ravulizumab (Ultomiris®) HTA ID: 20036
Dabrafenib plus Trametinib (Tafinlar® plus Mekinist®)
Vedolizumab (Entyvio®) HTA ID: 20029
Vedolizumab (Entyvio®) HTA ID: 20030
Brigatinib (Alunbrig®) HTA ID: 20031
Apalutamide (Erleada®) for nmCRPC
Ibrutinib (Imbruvica®) HTA ID:20032
IUB™ Ballerine® MIDI 15mm diameter SCU300B. HTA ID: 20027
Daratumumab (Darzalex®) HTA ID: 20025
Pegylated liposomal irinotecan (Onivyde®) HTA ID: 20028
Bempedoic acid/Ezetimibe (Nustendi®) HTA ID: 20026b
Bempedoic acid (Nilemdo®) HTA ID: 20026a
Lanadelumab (Takhzyro®)
Indacterol/mometasone furoate (Atectura®) HTA ID: 20024
Indacterol/glycopyrronium/mometasone furoate (Enerzair®). HTA ID: 20023
Darolutamide (Nubeqa®). HTA ID: 20022
Letermovir (Prevymis®)
Pembrolizumab (Keytruda®) for Adjuvant melanoma
Hydroxycarbamide solution (Xromi®). HTA ID: 20020
Onasemnogene abeparvovec (Zolgensma®). HTA ID: 20021
Naloxone (Nyxoid®) intranasal spray. HTA ID: 20019
Durvalumab (Imfinzi®)
House Dust Mite Extract (Acarizax ®) for Allergic Asthma. HTA ID: 20016
House Dust Mite Extract (Acarizax ®) for Allergic Rhinitis. HTA ID: 20015
Benralizumab (Fasenra®) Autoinjector. HTA ID: 20018.
Andexanet alfa (Ondexxya®). HTA ID: 20014
Liposomal daunorubicin and cytarabine (Vyxeos Liposomal®)
Estradiol (Oestrogel® Pump Gel). HTA ID: 20013
Brolucizumab (Beovu®). HTA ID: 20009
Meropenem/vaborbactam (Vaborem®). HTA ID: 20007
Avatrombopag (Doptelet®). HTA ID: 20006
Olaparib (Lynparza®) (1L maintenance of BRCA-mutated advanced OVCA)
Infliximab (Remsima SC®). HTA ID: 20012
Apalutamide (Erleada®). HTA ID: 20010
Pegaspargase (Oncaspar®) powder for solution for injection/infusion. HTA ID: 20003
Burosumab (Crysvita®)
Cannabidiol (Epidyolex®) for the treatment of Lennox-Gastaut Syndrome. HTA ID: 20005
Cannabidiol (Epidyolex®) for the treatment of Dravet Syndrome. HTA ID: 20004
Alutard SQ® honey bee and Alutard SQ® wasp venoms. HTA ID: 19038
Ravulizumab (Ultomiris®) HTA ID: 19054
Trastuzumab emtansine (Kadcyla®) HTA ID: 20002
Patisiran (Onpattro®)
Axicabtagene Ciloleucel (Yescarta®)
Pegvaliase (Palynziq®) HTA ID: 20001
Lutetium (177Lu) Oxodotreotide (Lutathera®)
Esketamine (Spravato®) HTA ID: 19055
Olaparib (Lynparza®) for platinum sensitive relapsed ovarian cancer
Neratinib (Nerlynx®) HTA ID: 19057
Brentuximab vedotin (Adcetris®) for CD30+ Hodgkins lymphoma HTA ID: 19058
Dupilumab (Dupixent®) HTA ID: 19056
Siponimod (Mayzent®) HTA ID: 19053
Co-enzyme Q10 (CoQun®) HTA ID: 19045
Larotrectinib (Vitrakvi ®) HTA ID: 19050
Nivolumab (Opdivo®) in combination with ipilimumab (Yervoy®)
Fluoride toothpaste (Duraphat® 5,000 ppm)
Pembrolizumab (Keytruda®) for head and neck squamous cell carcinoma. HTA ID: 19051
Avelumab (Bavencio®) in combination with axitinib (Inlyta®) for first line treatment of metastatic renal cell carcinoma. HTA ID: 19046
2019
Methyl aminolevulinate (Metvix®) HTA ID: 19049
Ustekinumab (Stelara®) for Ulcerative colitis HTA ID: 19048
Dupilumab (Dupixent®)
Upadacitinib (Rinvoq®) HTA ID: 19047
Midostaurin (Rydapt®) for AML
Gilteritinib (Xospata®) for Relapsed or Refractory AML. HTA ID: 19043
Progesterone (micronised) (Utrogestan®)
Certolizumab pegol (Cimzia ®) for moderate to severe plaque psoriasis
Venetoclax (Venclyxto®) in combination with rituximab
Mepolizumab (Nucala®) 100mg solution in pre-filled pen and syringe
Levonorgestrel Intrauterine System (Levosert®)
Zanamivir (Dectova®)
Nivolumab (Opdivo®) as monotherapy for the adjuvant treatment of adults with melanoma
Argipressin acetate (Embesin®)
Trientine Tetrahydrochloride (TETA 4HCL) – Cuprior®
Inotersen (Tegsedi®)
Erenumab (Aimovig®)
Darvadstrocel (Alofisel®)
Blinatumomab (Blincyto®) CD19+ BCP-ALL
Tisagenlecleucel (Kymriah®) for DLBCL
Tildrakizumab (Ilumetri®). HTA ID: 19029
Tisagenlecleucel (Kymriah®) for pALL
Dolutegravir/Lamivudine (Dovato®)
Doxylamine/Pyridoxine (Xonvea®)
Pembrolizumab (Keytruda®) 1L NSCLC with chemotherapy
Niraparib (Zejula®)
Olaparib (Lynparza®) tablets for BRCA-mutated platinum sensitive relapsed ovarian, fallopian tube, or primary peritoneal cancer
Osimertinib (Tagrisso®) for the first-line treatment of metastatic NSCLC
Romiplostim (Nplate®)
Ribociclib (Kisqali®) – Updated License
Gemtuzumab ozogamicin (Mylotarg®)
Lorlatinib (Lorviqua®)
Rivaroxaban (Xarelto®) for the prevention of atherothrombotic events
Levodopa 20mg/ml + carbidopa monohydrate 5mg intestinal gel (Duodopa®)
Atezolizumab (Tecentriq® ) for Urothelial Carcinoma 2L
Risankizumab (Skyrizi®) HTA ID: 19010
Vestronidase alfa (MEPSEVII®)
Magnesium Aspartate Dihydrate (Magnaspartate®)
Dacomitinib (Vizimpro®)
Stiripentol (Diacomit®)
Mannitol Dry Powder (Bronchitol®)
Olaparib (Lynparza®) for breast cancer
Opium Tincture (Dropizol®
Pembrolizumab (Keytruda ®) 1L squamous NSCLC with chemotherapy
Cerliponase alfa (Brineura®)
Pembrolizumab (Keytruda ®) for Urothelial Carcinoma 2L
Carfilzomib (Kyprolis®) in combination with dexamethasone (CAR+DEX).
Daratumumab (Darzalex®) in combination with bortezomib and dexamethasone
Liraglutide (Victoza®)
Patiromer (Veltassa®)
Enzalutamide (Xtandi®) for nmCRPC
Pertuzumab (Perjeta®) for Adjuvant HER2 positive breast cancer
Blinatumomab (Blincyto®) (paediatric ALL)
Budesonide orodispersible tablet (Jorveza®)
Pentosan Polysulfate Sodium [PPS] (Elmiron®)
Tivozanib (Fotivda®)
Encorafenib (Braftovi®), binimetinib (Mektovi®)
Diclofenac (Itami®)
Doravirine (Pifeltro®)
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (Delstrigo®)
Alectinib (Alecensa®)
2018
Cariprazine (Reagila®)
Ozenoxacin (Dubine®)
Ropivacaine Readyfusor®
Brigatinib (Alunbrig®)
Lesinurad (Zurampic®)
Ixekizumab (Taltz®) for psoriatic arthritis
Abiraterone acetate (Zytiga®) for mHSPC
Dinutuximab beta (Qarziba®)
Avelumab (Bavencio®)
Ocrelizumab (Ocrevus®) for PPMS
Atezolizumab (Tecentriq®)
Tofacitinib (Xeljanz®) for Ulcerative Colitis
Inotuzumab ozogamicin (Besponsa®)
Nivolumab (Opdivo®) for urothelial carcinoma
Tolvaptan (Jinarc®)
Midostaurin (Rydapt®) for ASM
Idebenone (Raxone®)
Ocrelizumab (Ocrevus®) for RMS
Lenvatinib (Lenvima®) for HCC
Ribociclib (Kisqali®)
Pembrolizumab (Keytruda ®) for Urothelial Carcinoma 1L
Urea (GlucoRx Allpresan®)
Cladribine (Mavenclad®)
Dolutegravir/Rilpivirine (Juluca®)
Cabozantinib (Cabometyx®)
Venetoclax (Venclyxto®)
Glycerol Phenylbutyrate (Ravicti®)
Fluticasone furoate/ umeclidinium/ vilantero (Trelegy™ Ellipta™)
Sebelipase alfa (Kanuma®)
Bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy®)
Pembrolizumab (Keytruda®) for NSCLC (second line)
Selexipag (Uptravi®)
Ertugliflozin (Steglatro®)
Recombinant Human Parathyroid Hormone (Natpar®)
Evolocumab (Repatha®)
Tafamadis meglumine (Vyndaqel®)
Naltrexone / bupropion (Mysimba®)
Osimertinib (Tagrisso®)
Obinutuzumab (Gazyvaro®) for previously untreated advanced follicular lymphoma
Eliglustat (Cerdelga®)
Blinatumomab (Blincyto®)
Semaglutide (Ozempic®)
Delta-9-tetrahydrocannabinol/Cannabidiol, THC/CBD (Sativex®)
Teduglutide (Revestive®)
Brentuximab vedotin (Adcetris®) for CD30+ cutaneous T-cell lymphoma (CTCL)
Benralizumab (Fasenra®)
Dimethyl fumarate (Skilarence®)
Guselkumab (Tremfya®)
Modified Release Hydrocortisone (Plenadren®)
2017
Pembrolizumab (Keytruda ®) for Classical Hodgkin Lymphoma
Emtricitabine/tenofovir disoproxil (TEVA®)
Nusinersin (Spinraza®)
Ixazomib (Ninlaro®)
Tramadol hydrochloride/dexketoprofen (Skudexa®)
Hyaluronic acid and co enzyme Q10 (VisuXL®)
Daratumumab (Darzalex®) in combination with lenalidomide and dexamethasone
Rivaroxaban (Xarelto®) low dose for prevention of recurrent venous thromboembolism
Rivaroxaban (Xarelto®) for Atrial Fibrillation patients undergoing PCI
Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi®)
Cysteamine bitartrate delayed-release (Procysbi®)
Lacosamide (Vimpat ®)
Obeticholic acid (Ocaliva®)
Darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide (Symtuza®)
Sofosbuvir/Velpatasvir (Epclusa®) chronic hepatitis C virus (HCV) – pangenotypic
Pembrolizumab (Keytruda®) for NSCLC (first line)
Sarilumab (Kevzara®)
Sapropterin (Kuvan®)
Etelcalcetide (Parsabiv®)
Glecaprevir/Pibrentasvir (Maviret®)
Brodalumab (Kyntheum®)
Follitropin delta (Rekovelle®)
Palbociclib (Ibrance®)
Emtricitabine / tenofovir disoproxil fumarate (Truvada®)
Baricitinib (Olumiant®)
Pitolisant hydrochloride (Wakix®)
Insulin aspart (Fiasp®)
Bezlotoxumab (Zinplava®)
Ceftazidime-avibactam (CEF-AVI)(Zavicefta®)
Rolapitant (Varuby®)
Human alpha1-proteinase inhibitor (A1PI) (Prolastin®)
Alirocumab (Praluent®)
Migalastat (Galafold®)
Lenvatinib (Kisplyx®)
Nivolumab (Opdivo®) for head and neck cancer
Dalbavancin (Xydalba®)
Tofacitinib (Xeljanz®)
Everolimus (Votubia ®) for refractory seizures associated with tuberous sclerosis complex (TSC)
Crizotinib (Xalkori®) for ROS1 NSCLC
Crizotinib (Xalkori®) for first line ALK+ NSCLC
Glycopyrronium bromide (Sialanar®)
Nivolumab (Opdivo®) for advanced renal cell carcinoma
Levonorgestrel intrauterine delivery system LNG IUS 12 (Kyleena®)
Trametinib (Mekinist®)
Daratumumab (Darzalex®)
Mepolizumab (Nucala®) 100mg powder for solution for injection
Reslizumab (Cinqaero®)
Amsacrine (Amsidine®)
Epoprostenol (Veletri®)
Obinutuzumab (Gazyvaro®) for Follicular Lymphoma
Nivolumab (Opdivo®) for classical Hodgkin Lymphoma
Ustekinumab (Stelara®) for Crohn’s Disease
Cobimetinib (Cotellic®)
Ivacaftor (Kalydeco®) for the treatment of CF patients with the R117H mutation.
2016
Phenylephrine Hydrochloride, Tropicamide & Lidocaine Hydrochloride (Fydrane®)
Human alpha1-proteinase inhibitor (Respreeza®)
Elosulfase alfa (Vimizim®)
Daclizumab (Zinbryta®)
Vortioxetine (Brintellix®)
Nivolumab plus ipilimumab (Opdivo® plus Yervoy®)
Carfilzomib (Kyprolis®) in combination with lenalidomide and dexamethasone (CAR+LEN+DEX)
Insulin degludec/liraglutide (IDegLira) (Xultophy®)
Elbasvir/Grazoprevir (Zepatier®)
Ivacaftor (Kalydeco®) for patients with CF 2 years +
Nivolumab (Opdivo®) for non-squamous NSCLC
Ferric maltol (Feraccru®)
Aceclofenac (Vitafen®)
Ibrutinib (Imbruvica®) for previously untreated CLL
Sofosbuvir/Velpatasvir (Epclusa®)
Ruxolitinib (Jakavi®) for Polycythaemia Vera 20008
Loxapine inhalation powder (Adasuve®)
Ixekizumab (Taltz®)
Ramucirumab (Cyramza®)
Trifluridine/tipiracil (Lonsurf®)
Rilpivirine (R), emtricitabine (F), tenofovir alafenamide (TAF) (Odefsey®)
Sacubitril/valsartan (Entresto®)
Safinamide methansulfonate (Xadago®)
Calcipotriol and betamethasone dipropionate cutaneous foam (Enstilar ®)
Lumacaftor/ivacaftor (Orkambi®)
Ulipristal acetate (Esmya ®) intermittent treatment
Etanercept (Benepali®)
Pertuzumab (Perjeta®) in neoadjuvant HER2 positive breast cancer
Isavuconazole (Cresemba®) for the treatment of invasive aspergillosis.
Isavuconazole (Cresemba®) for the treatment of mucormycosis
Ticagrelor (Brilique®)
Apremilast (Otezla®) for psoriatic arthritis.
Ataluren (Translarna®)
Emtricitabine/tenofovir alafenamide (Descovy®)
Ceftolozane/tazobactam (Zerbaxa®)
Nintedanib (Vargatef®)
Brivaracetam (Briviact®)
Sufentanil (Zalviso®)
Nivolumab (Opdivo®) for Melanoma
Talimogene Laherparepvec (Imlygic®)
Nivolumab (Opdivo®) for NSCLC
Levofloxacin (Quinsair®)
Fluocinolone acetonide intravitreal implant (Iluvien®) for diabetic macular oedema
Eltrombopag (Revolade®) for Severe Aplastic Anaemia (SAA)
Nintedanib (Ofev®)
Idelalisib (Zydelig®)
Paritaprevir boosted with ritonavir and ombitasvir (Vierkirax®) with or without dasabuvir (Exviera®)
Panobinostat (Farydak®)
Pembrolizumab (Keytruda®) for the first line treatment of unresectable or advanced metastatic melanoma in adults.
Pembrolizumab (Keytruda®) for the treatment of unresectable or advanced metastatic melanoma in adults refractory to ipilimumab.
Apremilast (Otezla®) for moderate to severe chronic plaque psoriasis.
Ciclosporin 1mg/ml eye drops (Ikervis®)
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir alafenamide (Genvoya®)
Ponatinib (Iclusig®)
2015
Methoxyflurane (Penthrox®)
Guanfacine hydrochloride (Intuniv®)
Idarucizumab (Praxbind®)
Olaparib (Lynparza®) capsules for BRCA-mutated platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer
Secukinumab (Cosentyx®) for Psoriatic Arthritis
Secukinumab (Cosentyx®) for Ankylosing Spondylitis
Lenalidomide (Revlimid®)
Iron (III) isomaltoside 1000 (Monover®)
Iron (III) isomaltoside 1000 (Diafer®)
Ledipasvir/sofosbuvir (Harvoni®)
Vedolizumab (Entyvio®) in Ulcerative Colitis
Vedolizumab (Entyvio®) in Crohn’s Disease
Netupitant/palonosetron (Akynzeo®)
Insulin Glargine (Abasaglar®)
Ibrutinib (Imbruvica®) for MCL
Ibrutinib (Imbruvica®) for CLL
Lidocaine 5% plasters (Versatis®)
Secukinumab (Cosentyx®) for moderate to severe plaque psoriasis
Tedizolid phosphate (Sivextro®)
Ceritinib (Zykadia®)
Camellia sinensis, folium (green tea leaf) (Catephen 10%®)
Lenvatinib (Lenvima®)
Edoxaban (Lixiana®)
Insulin Glargine U300 (Toujeo®)
Omalizumab (Xolair®) for the treatment of severe allergic asthma
Enzalutamide (Xtandi®) pre chemotherapy
Daclatasvir (Daklinza®)
St Johns Wort (Pacifa®)
Insulin Degludec (Tresiba®)
Dulaglutide (Trulicity®)
Naloxegel (Moventig®)
Obinutuzumab (Gazyvaro®) for Lymphocytic Leukaemia
Pixantrone (Pixuvri®)
Simeprevir (Olysio®) in combination with Sofosbuvir
Pomalidomide (Imnovid®)
Bedaquiline (Sirturo®)
Aclidinium bromide / formoterol fumarate dihydrate (Brimica® Genuair®)
Dimethyl fumarate (Tecfidera®)
Telavancin (Vibativ®)
Darunavir & cobicistat (Rezolsta®)
2014
Pegylated Interferon beta-1a (Plegridy ®)
Ofatumumab (Arzerra®) (Previously untreated Chronic Lymphocytic Leukaemia)
Pregabalin (Lyrica®) for the treatment of Generalised Anxiety Disorder
Radium-223 (Xofigo®)
Sofosbuvir (Solvaldi®)
Polynuclear iron(III)-oxyhydroxide (pn-FeOOH) (Velphoro®)
Regorafenib (Stivarga®) for GIST
Rituximab (MabThera®)
Lomitapide (Lojuxta®)
Nab-paclitaxel (Abraxane®)
Canagliflozin (Invokana®)
Insulin aspart (NovoRapid® FlexTouch ®)
Apixaban (Eliquis®) for treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults
Cabozantinib (Cometriq®)
Aripiprazole (Abilify Maintena®)
Lixisenatide (Lyxumia®)
Tocilizumab SC (RoActemra®)
Defibrotide (Defitelio®)
Simeprevir (Olysio®)
Umeclidinium/vilanterol (Anoro®)
Bosentan (Tracleer®)
Ambrisentan (Volibris®)
Alemtuzumab (Lemtrada®)
Trastuzumab emtansine (Kadcyla®)
Dabrafenib (Tafinlar®)
Regorafenib (Stivarga®) for mCRC
Buprenorphine/naloxone (Suboxone®)
Teriflunomide (Aubagio®)
Omalizumab (Xolair®)
Dabigatran Etexilate (Pradaxa®) for the treatment of DVT and PE
Empagliflozin (Jardiance®)
Tadalafil (Adcirca®)
Sildenafil (Revatio®)
Riociguat (Adempas®)
Brimonidine 3.3 mg/g gel (Mirvaso®)
Clindamycin 1% with tretinoin 0.025% (Treclinac®)
Oladaterol (Striverdi®, Respimat®)
Avanafil (Spedra®)
Brentuximab vedotin (Adcetris®)
Enzalutamide (Xtandi®) on or after chemotherapy
Nalmefene (Selincro®)
Sodium Chloride 70mg/ml, Sodium Hyaluronate 1mg/ml (Hyaneb®)
Dolutegravir (Tivicay®)
Abiraterone acetate (Zytiga®) for mCRPC post ADT
Incobotulinum Toxin Type A (Xeomin®)
Meningitis B Vaccine – February 2014
Eltrombopag (Revolade®) for Thrombocytopenia in HCV
Aflibercept (Zaltrap®)
Macitentan (Opsumit®)
Liquid Paraffin Ointment (VitA-POS Opthalmic®)
Sodium Hyaluronate (Hyloforte® 0.2%)
Sodium Hyaluronate (Hylotear® 0.1%)
Vismodegib (Erivedge®)
2013
Dapagliflozin (Forxiga®)
Fluticasone furoate/vilanterol (Relvar™ Ellipta™)
Abatacept (Orencia®)
Alogliptin (Vipidia®)
Golimumab (Simponi®) for UC
Pregabalin (Lyrica®) for the treatment of neuropathic pain
Ulipristal acetate (Esmya®) single course treatment
Afatinib (Giotrif®)
Eculizumab (Soliris®)
Bosutinib (Bosulif®)
Lipegfilgrastim (Lonquex®)
Infliximab (Inflectra®)
Imiquimod 3.75% (Zyclara®)
Pertuzumab (Perjeta®)
Crizotinib (Xalkori®)
Rifaximin (Targaxan®)
Sodium phenylbutyrate (Pheburane®)
Icatibant (Firazyr®)
Perampanel (Fycompa®)
Ruxolitinib (Jakavi®)
Ocriplasmin (Jetrea®)
Linaclotide (Constella®)
Colistimethate sodium (Colobreathe®)
Vandetanib (Caprelsa®)
Apixaban (Eliquis®) for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil (as fumarate)(Stribild®)
Omega-3-acid ethyl esters (Omacor®)
Levonorgestrel intrauterine system LNG-IUS (Jaydess®)
Pirfenidone (Esbriet®)
Lisdexamfetamine dimesylate (Tyvense®)
Azelastine hydrochloride and fluticasone propionate (nasal spray) (Dymista®)
Fidaxomicin (Dificlir®)
Ivacaftor (Kalydeco®)
Mirabegron (Betmiga®)
2012
Aflibercept (Eylea®)
Decitabine (Dacogen®)
Bendamustine (Levact®)
Eribulin (Halaven®)
Ingenol mebutate gel (Picato®)
Axitinib (Inlyta®)
C1inhibitor (human) (Cinryze®)
Aclidinium bromide (Eklira Genuair®)
Everolimus (Afinitor®)
Ceftaroline (Zinforo®)
Vemurafenib (Zelboraf®)
Fampridine (Fampyra®)
Ferumoxytol (Rienso®)
Glycopyrronium bromide (Seebri Breezhaler®)
Capsaicin 8%w/w patch (Qutenza®)
Apixaban (Eliquis®) for the prevention of venous thromboembolic events in adult patients who have undergone elective hip or knee replacement surgery
Rivaroxaban (Xarelto®) for the Prevention of Stroke in Atrial Fibrillation
Piperaquine tetraphosphate/dihidroartemisinin (Eurartesim®)
Abiraterone Acetate (Zytiga®) for mCRPC
Aspirin 81mg/Esomeprazole 20mg (Axanum®)
Pasireotide (Signifor®)
Tegafur/Gimeracil/Oteracil (Teysuno®)
Dexamethasone Intravitreal Implant (Ozurdex®)
Cabazitaxel (Jevtana®)
Rivaroxaban (Xarelto®) for the Treatment of Deep Vein Thrombosis
Belatacept (Nulojix®)
Telaprevir (Incivo®)
Boceprevir (Victrelis®)
Azilsartan (Edarbi®)
Rilpivirine (Edurant®)
Nomegestrol acetate/estradiol (Zoely®)
2011
Amifampridine (Firdapse®)
Denosumab (Xgeva®)
Lotemax 0.5% eye drops suspension (Loteprednol)
Regadenoson (Rapiscan®)
Everolimus (Votubia®)
Grass pollen allergen extract (Oralair®)
Ticagrelor (Brilique®)
Oncotype DX®
Fingolimod (Gilenya®)
Asenapine (Sycrest®)
Catumaxomab (Removab®)
Dexmedetomidine (Dexdor®)
Hydroxycarbamide (Siklos®)
Ipilimumab (Yervoy®)
Linagliptin (Trajenta®)
Belimumab (Benlysta®)
Dabigatran etexilate (Pradaxa®) – for the prevention of stroke and systematic embolisom in atrial fibrillation
Lornoxicam (Xefo®)
Nepafenac (Nevanac®)
Velaglucerase Alfa (VPRIV®)
Collagenase Clostridium Histolyticum (Xiapex®)
Exenatide (Bydureon®)
Adalimumab (Humira®)
Vernakalant (Brinavess®)
Tapentadol (Palexia®)
Paliperidone palmitate (Xeplion®)
Tafluprost (Saflutan®)
Retigabine (Trobalt®)
Prucalopride (Resolor®)
Bilastine (Drynol®)
Iron isomaltoside 1000 (MonoVer®)
Bazedoxifene (Conbriza®)
2010
Pitavastatin (Livazo®)
Tobramycin (TOBI Podhaler®)
Gefitinib (Iressa®)
Eltrombopag (Revolade®) for ITP
Roflumilast (Daxas®)
Corifollitropin alfa (Elonva®)
Nilotinib (Tasigna®) newly diagnosed CML
Dienogest (Visanne®)
Certolizumab pegol (Cimzia®)
Denosumab (Prolia®)
Mifamurtide (Mepact®)
Oxycodone/naloxone (Targin®)
Ofatumumab (Arzerra®) (Refractory CLL)
Golimumab (Simponi®)
Colesevelam (Cholestagel®)
Prasugrel (Efient®)
Rotavirus Vaccine
Indacaterol (Onbrez®)
Dronedarone (Multaq®)
2009
Agomelatine (Valdoxan®)
Ustekinumab (Stelara®)
Adenuric (Febuxostat®)
Ranolazine (Ranexa®)
Degarelix (Firmagon®)
Eslicarbazepine (Zebinix®)
Glucosamine sulfate (Dona®)
Colorectal Cancer Screening programme
2008
Rivaroxaban (Xarelto®) for the Primary Prevention of Venous Thromboembolic Events after Total Hip/Knee Replacement
Dabigatran Etexilate (Pradaxa®) for the Primary Prevention of Venous Thromboembolic Events after Total Hip/Knee Replacement
Melatonin (Circadin®)
Human Papillomavirus Vaccine
Nilotinib (Tasigna®) CML resistant/intolerant to imatinib
Lapatinib (Tyverb®)
2007
Sublingual Immunotherapy (Grazax®)
Natalizumab (Tysabri®)
Universal Infant Hepatitis B Vaccination programme
Pneumococcal conjugate vaccine
2006
Sunitinib (Sutent®)
Rimonabant (Acomplia®)
Inhaled insulin (Exubera®)
health check